Companies researching Xtandi (Enzalutamide)
Enzalutamide, marketed under the brand name Xtandi, is a nonsteroidal antiandrogen drug used to treat prostate cancer.
6
companies
List of companies that research Xtandi (Enzalutamide)
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
Japan | Pharmaceutical Manufacturing | 12k | Xtandi (Enzalutamide) | ||
United Kingdom | Research Services | 1.6k | $35M | Xtandi (Enzalutamide) | |
United States | IT Services and IT Consulting | 52 | Xtandi (Enzalutamide) |
Showing top companies out of 6 that research Xtandi (Enzalutamide). Get the full list on TheirStack.
Frequently asked questions


